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ReviewDo Disorders of Movement Cause
Movement Disorders and Dementia?
along which molecular motor proteins convey cargoes
and activated signaling complexes over long distances.
These physical transport processes are not only criti-
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Howard Hughes Medical Institute
Department of Cellular and Molecular Medicine
School of Medicine cal to normal neuronal function but they also appear to
be the “Achilles heel” of these large cells, whose sizeUniversity of California, San Diego
La Jolla, California 92093 may predispose them to both specific and nonspecific
insults to the transport machinery. For example, recent
discoveries demonstrate that some neurodegenerative
diseases can be caused by mutations in motor proteinNeurons require long-distance microtubule-based
transport systems to ferry vital cellular cargoes and genes and related components. In addition, the long
length and sometimes narrow diameter of the support-signals between cell bodies and axonal or dendritic
terminals. Considerable progress has been made on ing axons and dendrites may predispose these gigantic
cells to nonspecific blockages. As discussed below, dis-developing a molecular understanding of these pro-
cesses and how they are integrated into normal neu- eases of this type may include not only rare pathologies,
but also some of the most common and life-threateningronal functions. Recent work also suggests that these
transport systems may fail early in the pathogenesis of illnesses, including Alzheimer’s disease, polygluta-
mine and other protein aggregation diseases such asof a number of neurodegenerative diseases.
Huntington’s disease, and perhaps even some forms of
Lou Gehrig’s disease (ALS).Neurons face a serious problem created by the great
distance between major sites of biosynthesis in the cell In this review, I briefly summarize the major concepts
we now accept about the neuronal transport machinerybody and major sites of signaling, cellular interactions,
and stress sensing. These cells are usually thought of and highlight a few recent advances of exceptional inter-
est. I then describe a number of recent findings thatas having a rapid communication system, the action
potential, which, like email or the internet, allows a great suggest that defects in neuronal transport may be cen-
tral to a number of different neuronal diseases and illus-deal of information to be transmitted rapidly between
various cellular sites. Yet, like human communications, trate several emerging generalities: (1) Proteins impli-
cated in neurodegenerative disease such as huntingtinthese cells cannot live without “snail mail.” Large pack-
ages, critical supplies, and perhaps the most sensitive or and amyloid precursor protein (APP) are often trans-
ported in axons; (2) Some proteins implicated in diseaselife-threatening of communications must be physically
transmitted. Thus, the large size of these cells makes such as amyloid precursor protein, huntingtin, preseni-
lin, and tau interact with the transport machinery; (3)them particularly reliant upon their long-distance trans-
port systems to support their functions, viability, and Reduction or excess of disease-causing proteins can
cause axonal transport phenotypes (axonal blockages)differentiation. For example, the axonal terminus and
the axon itself, depend upon a continuous delivery of in Drosophila and mouse; and (4) Axonal transport phe-
notypes caused by disease-related proteins such asorganelles, vesicles, cytoskeletal proteins, signaling
molecules, and other supplies from the cell body. Simi- APP in Drosophila exhibit strong genetic interactions
with motor protein mutations.larly, the cell body depends upon retrograde transport
of signals from distant target cells to monitor the integ-
rity of target connections and to sense damage to the The Long-Distance Transport Machinery
intermediary supply lines of the axon. Dendritic arrays Is Composed of Molecular Motors
of neurons have similar challenges since they can also and Microtubules
be large owing to substantial length and branching. Microtubules are linear polar polymers that have plus
A simple scaling operation illuminates the magnitude and minus ends reflecting their structural and kinetic
of the problem. A 30–50 m diameter motor or sensory polarity. Microtubules in neurons are organized ac-
neuron cell body can support a 1 m axon that runs from cording to polarity with the plus ends in axons pointing
the spinal cord to the big toe in the human peripheral toward synapses and the minus ends directed toward
nervous system (PNS). Converting microns to feet cell bodies (Figure 1) (Heidemann et al., 1981). There
scales this problem to human proportions with the result are two major types of motor proteins that support long-
that the equivalent of a 30–50 foot diameter room sup- distance transport along microtubules—kinesins and
ports an axon that is almost 200 miles long. Most chemi- dyneins (for more extensive recent reviews, see Gold-
cal communications and supplies are manufactured in stein, 2001; Goldstein and Yang, 2000; Vale, 2003). Axo-
this 30–50 foot room and transported 200 miles through nal transport thus relies upon kinesin motors to drive
a pipe that can be as large as 10–20 feet in diameter at anterograde transport from cell body to synapse. Dyn-
its start, but then may narrow substantially during its ein, and perhaps a few minus end-directed kinesins,
journey. We now understand that the long-distance sup- drive retrograde transport from synapse to cell body.
ply lines in axons and dendrites are primarily composed Microtubule organization in dendrites is more complex
of a system of polarized microtubule tracks (Figure 1) than in axons (Figure 1). Proximal dendrites were re-
ported to contain a mix of cell body-directed minus and
plus ends while distal dendrites are similar to axons with*Correspondence: lgoldstein@ucsd.edu
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Figure 1. Diagram of “Typical” Neuron with
Multiple Dendrites (Red) and a Single
Branched Axon (Blue)
The polarity of microtubules (red) in different
regions of the neuron is indicated. A sche-
matic diagram of kinesin (olive green) and
dynein (orange) and their relative direction of
movement along microtubules is shown at
the bottom.
the plus ends of microtubules pointing away from the pate in coupling cargo interactions to motor activation.
Dyneins utilize a similar principle, but instead of havingcell body (Baas et al., 1988). Thus, transport in dendrites
may be more complex than transport in axons, although diversified motor subunits, tail and adaptor subunits are
apparently variable and may mediate a variety of cargoboth kinesins and dyneins seem to be used.
Motor proteins exhibit a simple set of organizational interactions (reviewed in Almenar-Queralt and Gold-
stein, 2001; Goldstein and Yang, 2000).principles resulting from evolutionary diversification (re-
viewed in Goldstein, 2001; Vale, 2003). In brief (Figure Myosins constitute another superfamily of motor pro-
teins that move along actin filaments. In neurons, actin is2), kinesins diversified by gene duplication such that
each kinesin motor protein contains a related motor concentrated in growth cones and at the cellular cortex,
where it is generally organized as an anastomosing net-domain that usually drives movement along microtu-
bules from minus ends to plus ends. Each kinesin motor work. This network of actin is thus most likely to support
local transport as opposed to the long-distance trans-polypeptide also has a different “tail” domain, often as-
sociated with other polypeptides, which appear to medi- port mediated by long microtubules (Atkinson et al.,
1992). Myosins have been recently reviewed (Berg etate attachment to cellular cargoes and perhaps partici-
Figure 2. Diagram Showing Types of Car-
goes, e.g., Vesicles and Organelles (Dark
Pink), Protein Complexes (Blue), and Cy-
toskeletal Filaments (Red), that Might Be Car-
ried by Kinesin (Olive Green) and Dynein (Or-
ange) Motor Proteins
Various proposed mechanisms for the inter-
action of motor proteins with cargoes are
shown in the box (green). Different diversifi-
cation strategies of kinesins and dynein are
shown at the bottom. For kinesins, genomic
and biochemical data suggest that most
eukaryotic genomes encode multiple kinesin
proteins with diverse tail domains and con-
served motor domains. For dyneins, genomic
and biochemical data suggest that most
eukaryotic genomes encode a small number
of well-conserved dynein motor polypeptides
and that functional diversity is generated by
encoding various dynein-associated poly-
peptides.
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al., 2001), so I highlight only those cases where myosins Retrograde transport from synapse to cell body is
also critical to neuronal viability and differentiation. Mosthave been implicated in human neuronal diseases or in
evidence supports the view that dynein drives the move-specific neuronal functions.
ment of most retrograde cargoes, although only a few
have been molecularly identified and characterized. OneMajor Neuronal Transport Pathways
such is marked by uptake of tetanus toxin, which travelsRadiolabeling and nerve ligation experiments form the
in a retrograde compartment distinct from endosomesclassic basis for dividing axonal transport into two major
but shared with the pathway moving neurotrophin re-categories—fast and slow (reviewed in Goldstein and
ceptors such as p75NTR to cell bodies (Lalli and Schi-Yang, 2000). Fast axonal transport moves at rates char-
avo, 2002). The movement of the neurotrophin receptoracteristic of vesicle and organelle motility driven by
TrkA from synapse to cell bodies is one of the best-kinesins and dyneins, i.e., on the order of 0.5–10 m per
studied cases where there is strong evidence for trans-second. The materials moved by fast axonal transport
port of an activated ligand-receptor vesicle signalingappear to be predominantly vesicles or organelles. Slow
complex (reviewed in Delcroix et al., 2003; Salehi et al.,anterograde axonal transport is 1–2 orders of magnitude
2003; Ye et al., 2003). Other cargoes are also movedslower and its general mechanism has been far more
from synapse to cell body, but the biological significancedifficult to elucidate than that of fast anterograde
of most of these movements is unknown.transport.
Transport in DendritesFast Axonal Transport
Selective transport into dendrites is poorly understoodSubstantial evidence supports the proposal that fast
and current experimental data do not provide much mo-anterograde axonal transport is driven by kinesin motor
lecular definition of the process. Thus, the observationproteins that link to vesicular and organellar cargoes
that some vesicles destined for dendrites selectively failand move them from cell bodies to synaptic endings.
to enter axons provides an important clue (Burack et al.,Well-supported examples include kinesin-I (historically
2000; Silverman et al., 2001). In addition, the discoveriesknown as conventional kinesin) driven movements of
that many different kinesin motor proteins are found invesicles containing amyloid precursor protein (APP),
dendrites suggests that kinesin-based movements mayGAP-43, and perhaps organelles such as mitochondria.
be critical to dendritic function and perhaps morpho-Other examples include synaptic vesicle proteins and/
genesis (reviewed in Goldstein and Yang, 2000). Foror synaptic vesicle precursors moved by members of
example, recent evidence led to the suggestion that twothe UNC-104 family of kinesins (KIF1) and spectrin-con-
critical dendritic cargo proteins are dependent upontaining vesicles moved by kinesin-II (KIF3A) (reviewed
different kinesins for their transport (Setou et al., 2000,in Almenar-Queralt and Goldstein, 2001). These move-
2002). The GluR2 subunit of the AMPA receptor appearsments appear simple in the sense that these motor pro-
to depend upon kinesin-I, and the NR2B subunit of theteins can be biochemically and genetically linked to
NMDA receptor appears to depend on KIF17. For GluR2,cargo transport. Yet, prudence, and inspection of the
it has been suggested that GRIP1 may bind to kinesindata, leads one to suspect that much is still not under-
heavy chain and direct it, and its cargoes, into dendrites
stood and that critical, and as yet unknown, regulatory
by an unknown mechanism. In addition, the discovery
mechanisms control the details and biological functions
of specific kinesins that are enriched in, or restricted to,
of the basic movements. For example, while KIF1A, a dendrites suggests that some motors may themselves
member of the UNC-104 family, has been argued to be exhibit specific targeting (Marszalek et al., 1999; Saito
processive on its own (Okada and Hirokawa, 1999, et al., 1997).
2000), persuasive recent data argue that this motor pro- Another transport problem that must be solved by
tein may actually be regulated by its state of oligomeriza- dendrites is posed by actin-rich dendritic spines ex-
tion, in turn controlled by phospholipid clustering during tending off of the dendritic shaft. It is likely that the
cargo association (Klopfenstein et al., 2002; Tomishige dendritic core primarily supports microtubule-based
et al., 2002). Thus, monomeric members of this family transport while the actin-rich spines may primarily sup-
may not be able to generate fast long-distance move- port myosin-based movements of vesicles and other
ments, but dimers induced by associating with phos- membranous components. Thus, delivery of postsynap-
pholipid-containing vesicles may become capable of the tic components, such as smooth ER and vesicles con-
long-distance processive movements needed to make a taining neurotransmitter receptors, into dendritic spines
one meter journey over a period of 1–10 days. Similarly, may rely upon a coordinated or sequential action of
a considerable amount of evidence suggests that con- motor proteins that are microtubule and then actin
ventional kinesin may not be active in its soluble, easily based. How this is accomplished is not known, but an
isolated form, but may instead be activated by cargo interesting model system may be provided by pigment
binding that induces unfolding and motor activation granule (melanosome) movements in specialized cells
(Coy et al., 1999; Friedman and Vale, 1999; Hackney such as melanocytes and melanophores (reviewed in
and Stock, 2000; Stock et al., 1999). Finally, the recent Gelfand, 2003). Melanosomes move away from the cell
discovery that JNK scaffolding proteins or JIPs (see center along microtubules in a dispersion phase and
below) may mediate the association of kinesin-I with inward in an aggregation phase. Dispersion includes
vesicles suggests that JNK and MAP kinase signaling movements along actin filaments that are interspersed
pathways may be intimately linked to the control of between microtubule tracks to ensure greater uniformity
kinesin-based movements (Bowman et al., 2000; Verhey during dispersion, a movement that must be reversed
during aggregation. A large body of recent excellentet al., 2001; Whitmarsh et al., 2001).
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work has revealed the major paradigms that support homologs of an IFT particle component in mouse photo-
the coordination of kinesin-II-, dynein-, and myosin Va- receptors gives rise to a failure of opsin transport from
based movements in these systems. In essence, myosin inner to outer segment and induction of apoptosis (Mar-
Va activity is reduced during aggregation, while its activ- szalek et al., 2000; Pazour et al., 2002). Thus, failure of
ity during outward motion removes melanosomes from these systems could lead to diseases such as retinitis
microtubule tracks and onto actin tracks to enhance the pigmentosa because of the failure to move opsin to outer
dispersion process. Coordination of myosin Va, kinesin- segments, which in turn appears to cause photoreceptor
II, and dynein is apparently achieved by a combination death. In this regard, it is interesting that at least one
of regulating myosin attachment by calcium calmodulin- class of dominant opsin mutants that cause retinitis
dependent kinase II and cAMP signaling through PKA. pigmentosa in humans have been suggested to have
Of interest in this context are myosin Va mutants in defects in transport from inner to outer segment (Por-
mouse and rat (Dekker-Ohno et al., 1993; Futaki et al., tera-Cailliau et al., 1994; Sung et al., 1994).
2000; Mercer et al., 1991). As expected, loss of myosin Slow Axonal Transport
Va causes a pigmentation phenotype. These mutants The mechanism of slow anterograde axonal transport
also exhibit a neurological phenotype characterized by has been a long-standing and persistent mystery. The
ataxia and spasms (opisthotonus) leading to early death. slow rate of movement, on the order of 0.01–0.001 m/s,
The cellular basis of this neurological phenotype is not has been very hard to reconcile with the relatively fast
entirely clear, but intriguingly, there are defects in the movements demonstrated by most molecular motor
membrane components of dendritic spines. Specifically, proteins tested in vitro (ca. 0.01–10 m/s). Thus, it has
these mutants lack smooth ER in dendritic spines of been suggested that intrinsically fast motor proteins,
Purkinje cells although glutamate receptors and a num- such as kinesin-I (which can move at velocities on the
ber of other postsynaptic proteins appear normal order of 1 m/s), may drive slow axonal transport by
(Petralia et al., 2001; Takagishi et al., 1996). The release possessing a low duty cycle, a low probability of associ-
of calcium in dendritic spines needed to induce long- ation with cargo, incorporation of cargo into static, non-
term depression is also abnormal in these animals (Mi- moving filamentous polymers, or a high probability of
yata et al., 2000). In humans, myosin Va mutants exhibit dissociation from cargoes or tracks (reviewed in Gold-
a disorder called Griscelli syndrome type 1, which is stein and Yang, 2000).
characterized by pigmentary defects and neurologic Recent work suggests that slow axonal transport may
dysfunction (OMIM entry #214450). Based on the data indeed be driven by fast components. For example,
thus far, it is tempting to speculate that a switch from kinesin-I appears to drive movements of intermediate
kinesin-based to myosin Va-based transport controls filaments in nonneuronal cells and in neurons (Prahlad
smooth ER delivery into dendritic spines and that the et al., 1998, 2000; Wang and Brown, 2001; Wang et
failure of this process is, at least in part, at the root al., 2000; Yabe et al., 1999). Strikingly, movement in
of the neuronal defects in Griscelli’s syndrome. Finally, neurons, at least in vitro, is characterized by infrequent
mutants in one component of the myosin Va receptor rapid movements punctuated by long pauses (Wang
complex on melanosomes, rab27a, give rise to pigmen- and Brown, 2001; Wang et al., 2000). Such behavior
tary defects and immune deficiencies but not neurologic could in principle convert rapid instantaneous move-
symptoms in mice and humans (Menasche et al., 2000; ments to slow net movements. Indeed, recent in vivo
Provance et al., 2002; Wilson et al., 2000; Wu et al., evidence is provided by the report that neuron-specific
2001, 2002a, 2002b). knockout of a neuron-specific kinesin-I heavy chain
Intraflagellar Transport in Sensory Neurons leads to apparent defects in neurofilament transport into
Another form of transport encountered in neurons may axons (Xia et al., 2003). How such a process may work
apply mostly to sensory neurons, which utilize a modi- or be regulated remains obscure as does definitive evi-
fied cilium or flagellum to support a sensory ending.
dence that fast motors drive slow transport.
There is excellent evidence that intraflagellar transport
(IFT) is required in motile cilia and flagella to move critical
Transport-Dependent Signalingcomponents from the cellular cytoplasm to the axo-
and Motor Proteinsnemal or ciliary end (reviewed in Rosenbaum and Wit-
How does a neuronal cell body and nucleus knowman, 2002). This movement appears to be driven by
whether it is coupled to appropriate targets and whetherkinesin-II for outward movements, by dynein for inward
its physical integrity is intact? This information is criticalmovements, and the motor-cargo association may be
to ensuring that appropriate transcriptional pathwaysmediated by a system of IFT particles that move along
are used and that appropriate materials are shipped intoaxonemal microtubules and in close apposition to the
axons and dendrities. Since nonneuronal cells rely uponplasma membrane. Those neurons that use a modified
MAP kinase-dependent stress signals to control genecilium to sense external stimuli, e.g., some mechanore-
activity in the nucleus in response to environmental orceptors, taste receptors, and photoreceptors, appear
other signals or damage, it is likely that neurons doto use the same transport system to move signaling
so as well. However, the large size of PNS neurons incomponents such as rhodopsin and arrestin (Marszalek
humans, e.g., a motor neuron, has the consequence thatet al., 2000; Pazour et al., 2002). This transport system
95% or more of the cytoplasmic volume is contained inmay also mediate some of the functions of these compo-
the axon. Thus, simple diffusion is unlikely to be suffi-nents such as the light-dependent movements of ar-
cient to distribute the damage signaling machinery or torestin and transducin between inner and outer segments
transmit biochemical damage signals such as activatedof photoreceptors (McGinnis et al., 2002). Recent work
indicates that loss of the kinesin-II motor protein or kinases. Instead, neurons appear to use biochemical
Review
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signals to determine if they are in contact with targets, that this vesicle eventually arrives and is an important
whether supply lines with targets are open, and whether part of the signaling process (reviewed in Salehi et al.,
repair pathways should be induced. 2003). How the vesicle is activated to move and what
A large body of work suggests that neurons respond motors drive the movement are key issues. While it is
to axotomy or other types of axonal damage by initiating likely that the major retrograde motor protein, dynein,
a complex program of cellular and transcriptional re- is responsible, this has not been conclusively docu-
sponses. Among these changes are elevations of acti- mented. Nonetheless, at least one report suggests that
vated JNK and AP-1 activity in neuronal cell bodies. An TrkA may interact directly with a dynein subunit (Yano
intriguing finding (Kenney and Kocsis, 1997a, 1997b) is et al., 2001), and an additional recent report suggests
that activation of JNK and AP-1 exhibits kinetics that that dynein is present in the same biochemical fractions
are consistent with a transport-mediated event in re- as NGF containing endosomes (Delcroix et al., 2003),
sponse to axonal damage. Specifically, the time needed providing, at least in part, a potential mechanism for
to send an activation signal is dependent upon the dis- movement. Whether TrkA signaling might regulate its
tance of the damage from the cell bodies. These findings own transport is an interesting and key question as is the
are particularly intriguing in light of recently discovered question of whether TrkA has other substrates during its
links between the vesicular transport machinery and long journey.
JNK scaffold proteins (see below). These studies raise
the possibility that molecules that activate new tran- Diseases of Transport
scriptional programs are present in axons where they Motor Protein Mutants
could signal to the cell body in response to damage. In Several diseases in humans have been linked directly
support of this idea, evidence that the transcription fac- to mutations in genes encoding motor proteins. For ex-
tor ATF-2 and MAP kinases of various types are trans- ample, one form of a peripheral neuropathy called CMT2
ported in axons has been reported (e.g., Middlemas et is caused by haploinsufficiency of KIF1B. KIF1B is a
al., 2003). kinesin motor protein implicated in movement of synap-
The study of damage signaling recently converged tic vesicle precursors and possibly mitochondria based
with studies of microtubule-based movements when it on experiments in the mouse (Nangaku et al., 1994; Zhao
was found that JNK scaffolding proteins, or JIPs, play et al., 2001). The finding that CMT2 can be caused by
a key role in linking kinesin-I to vesicular cargoes (Bow- reduction of KIF1B led to the proposal that reduced
man et al., 2000; Verhey et al., 2001; Whitmarsh et al., synaptic vesicle protein transport in humans may be a
2001). These JIP proteins fall into two families that are cause of peripheral neuropathy. Other recent examples
unrelated by sequence and mode of interaction with where disease is caused by motor protein gene muta-
kinesin-I but share the distinct characteristic that both tions are KIF5A missense mutations that have dominant
serve as scaffolding proteins upon which multiple sig- effects leading to one form of hereditary spastic paraple-
naling proteins of JNK signaling modules can simultane- gia (Reid et al., 2002) and dynactin mutations that cause
ously bind. For the JIP1/2 family of proteins, the extreme an ALS-like motor neuron degeneration (Puls et al.,
C terminus binds to kinesin light chain while another
2003). In these cases, it is likely that reduced transport
domain has been proposed to interact with members
causes the phenotype, although precisely what materi-
of the LDL-receptor supergene family such as ApoER2,
als fail to be moved and their relationships to disease
megalin, and LRP (Gotthardt et al., 2000; Stockinger et
symptoms are not entirely clear.al., 2000). Evidence has also been reported that JIP1
Additional types of motor protein mutations that mightcan bind amyloid precursor protein, APP, perhaps to
cause human disease are suggested by mouse motormediate transport or signaling (see below). The other
protein mutants that exhibit phenotypes characteristicfamily, exemplified by JIP3, aka sunday driver or syd,
of a variety of human diseases. For example, tissue-also binds kinesin light chain, but the binding motif in
specific knockouts of KIF3A cause retinitis pigmentosaJIP3 is almost certainly different from that in JIP1/2. The
(RP)-like disease when removed in photoreceptors andnature of the syd/JIP3 vesicle remains unknown as does
a syndrome resembling polycystic kidney disease whenthe significance of these linkages. While the phenotype
removed in the kidney (Lin et al., 2003; Marszalek et al.,of syd mutants suggests that this linkage is likely to be
2000). These KIF3A mutations are of interest because ofrequired for normal transport, whether a kinesin-JIP-
the existence of a number of genetically heterogeneouskinase-vesicle complex is in fact formed or needed dur-
human diseases in which RP and polycystic kidney dis-ing transport is unknown. Perhaps the most intriguing
ease are associated, sometimes with other disease phe-issue is whether the JNK system regulates kinesin-I dur-
notypes. In this regard, it is striking that a mouse muta-ing transport, whether it is only needed at the synapse
tion, Tg737, which appears to alter a component of theand is thus a “hitch-hiker,” or whether JNK signaling in
IFT particles of the transport machinery powered byresponse to damage is an important function of this
KIF3A also gives this type of phenotype, raising thesystem.
possibility that this class of diseases can be caused byOne of the most thoroughly studied neuronal bio-
lesions in the motor proteins and IFT subunits of the IFTchemical signaling processes is one in which neuro-
system in cilia and flagella (Pazour et al., 2002; Pazourtrophins interact with Trk-type receptors at nerve termi-
and Rosenbaum, 2002; Rosenbaum and Witman, 2002).nals and transduce a signal to the cell body some
Other examples are provided by mouse dynactin mu-distance away. While there has been a debate about
tations and transgenes that cause motor neuron degen-whether the initial signal reaches the cell body before
eration, and which may provide a good model for someor after the arrival of a vesicular complex containing
NGF, TrkA, and activated MAP kinases, there is no doubt types of ALS (Hafezparast et al., 2003; LaMonte et al.,
Neuron
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2002). Of relevance to these findings are the observa- confirmed in the Drosophila system (Gunawardena and
Goldstein, 2001; Torroja et al., 1999).tions that (1) mouse models of hereditary ALS caused by
Another potential link of AD to axonal transport comestransgenes expressing mutant superoxide disumutase 1
from the observation that presenilin interacts with theexhibit early reductions in slow axonal transport (Wil-
kinase GSK-3 (Takashima et al., 1998). It has recentlyliamson and Cleveland, 1999), (2) overexpression of neu-
been found that GSK-3 can phosphorylate kinesin lightrofilament subunits causes an ALS-like phenotype (Xu
chains leading to kinesin dissociation from membraneset al., 1993), and (3) neurofilament accumulations con-
(Morfini et al., 2002). Presenilin mutations that causesistent with transport failure are often seen in ALS (Mu-
familial AD appear to enhance GSK-3 activation, lead-noz et al., 1988). Together these data raise the possibility
ing to a net drop in kinesin-mediated transport (Piginothat axonal transport is a key early or causative feature
et al., 2003). It has been suggested that some forms ofof some types of ALS.
AD might be caused by defects of this type.Poisoning Transport by Motor Protein Adaptor
It is not yet clear how transport failures might be re-Mutants and Protein Aggregation
lated to proteolytic processing of APP to give rise toWhile mutants in genes encoding motor proteins may
A, the generally accepted toxic species in AD (Hardybe important players in human disease, there are two
and Selkoe, 2002; Selkoe, 2002). One possibility is thatadditional ways in which neurodegenerative disease
aggregated A may poison vesicle movement in narrowmight be caused by defects in transport. In the first,
axons nonspecifically. Alternatively, APP processing toproteins that regulate or interact with motor proteins
give rise to A may lead to dissociation of kinesin frommay cause disease when altered. In the second, nonspe-
APP-containing vesicles and consequent failures ofcific insults may trigger transport failures and subse-
transport. Finally, transport failures may be secondary toquent neuronal defects. These two categories may not
A-related toxicities. Thus, although an intriguing idea,be mutually exclusive, and are not yet entirely distin-
whether defective transport causes or plays an impor-guishable.
tant role in the development of AD needs to be testedAn example where defects in proteins that regulate
rigorously in humans.or interact with the transport machinery may be a part
It is noteworthy that neuronal defects in AD that canof disease causation or progression is provided by Alz-
be attributed to defective transport have been knownheimer’s disease (AD) and perhaps other dementias. In
for some time. For example, cholinergic enzymes areaddition to neuronal death and dysfunction, two patho-
reduced in the cortex while NGF levels are normal. Simi-logical features are typical of AD. One is the neurofibril-
larly, the response of basal forebrain cholinergic neu-lary tangles (NFT), which are aggregates of a microtu-
rons to cortical NGF appears reduced even though thesebule binding protein called tau. The other is the amyloid
neurons appear to express TrkA and the cortex appearsplaques, largely composed of proteolytic fragments of
to have normal levels of NGF (Bowen et al., 1982; De-the amyloid precursor protein, APP. Familial forms of
Kosky et al., 1992; Etienne et al., 1986; McGeer et al.,AD are caused by mutations in amyloid precursor pro-
1984; Mufson et al., 1994, 1995, 1997; Perry et al., 1978;tein (APP) or presenilin mutations, which have been
Sims et al., 1983; Wilcock and Esiri, 1982). In this regard,linked to processing of APP. Both APP and presenilin
it is striking that a mouse model of trisomy 21, in whichhave been suggested to travel together in axons and by
the APP gene is triplicated, exhibits defective NGF trans-interacting with kinesin-I either directly or indirectly to
port (Cooper et al., 2001).influence protein and vesicular traffic (Kamal et al., 2000,
Another potential link of AD to axonal transport comes2001; Morfini et al., 2002; Pigino et al., 2003). In addition,
from the tau protein aggregates consistently seen in ADthere is biochemical evidence that APP may interact
and some other dementias. For example, mutations indirectly (Kamal et al., 2000) with kinesin light chain to
the tau gene can cause a different dementia, FTDP-17,recruit kinesin-I to APP-containing vesicles. There are
which affects a different cellular population than AD,
also suggestions that interactions between APP and
although some of the cellular phenotypes are similar
kinesin-I may be simultaneously mediated or enhanced
(Ingram and Spillantini, 2002). Whether it is the aggre-
by JIP1 interactions with APP and kinesin light chain gates of tau per se or the changes in tau regulation of
(Inomata et al., 2003). Two important predictions of the microtubule motor-based movements that cause defec-
proposal that APP is an important component of kinesin- tive neuronal function is unclear. Of interest in this re-
I-based transport in axons is that loss of APP function gard, however, is the proposal that tau can regulate
or overexpression of domains of APP thought to interact kinesin-I-based traffic. Excess tau has been observed
with kinesin light chain should interfere with normal axo- to inhibit transport of organelles and vesicles toward
nal transport. These predictions have been validated in microtubule plus ends and into the axons of cultured
genetic experiments in Drosophila where axonal trans- neurons and neuron-like cells (Stamer et al., 2002). Tau
port defects can be caused by loss of the APP homolog, transgenic animals are also known to exhibit axonal
APPL, or overexpression of constructs of APPL or APP transport deficits (Ishihara et al., 1999; Spittaels et al.,
that contain the kinesin-I-interacting region (Gunawar- 1999). A potentially significant finding from these experi-
dena and Goldstein, 2001; Torroja et al., 1999). In mouse, ments is that peroxisomes are among the organelles
APP deletion mutations have also been shown to exhibit exhibiting transport failure in neuron-like cells express-
axonal transport deficits (Kamal et al., 2001). This hy- ing excess tau; these cells also become much more
pothesis also predicts that there should be strong ge- sensitive to oxidative damage (Stamer et al., 2002). Thus,
netic interactions between APP overexpression and re- transport failure could be a player in the oxidative dam-
ductions of kinesin-I dosage that would otherwise be age proposed to play a role in many of these disorders.
A final possible link of kinesin-I transport to AD isphenotypically benign. This prediction has also been
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provided by JIP1 and JIP2, which may link kinesin-I to pathology (Yang et al., 2000). Intriguingly, expression in
some membrane proteins including APP (in the case of Drosophila neurons of a number of different pathogenic
JIP1) and which have also been reported to interact polyglutamine proteins has been found to cause axonal
with proteins of the LDL receptor superfamily including blockages and to reduce the amount of motor proteins
megalin, LRP, and ApoER2 (Gotthardt et al., 2000; Ino- available to normal transport pathways (Gunawardena
mata et al., 2003; Matsuda et al., 2001; Stockinger et et al., 2003). Of interest is the related finding that axonal
al., 2000; Taru et al., 2002; Verhey et al., 2001; Whitmarsh torpedoes can also be caused by overexpression of
et al., 2001). These links are interesting in view of the the intermediate filament protein -internexin (Ching et
correlation between ApoE genotype and risk of late- al., 1999).
onset AD (Schmechel et al., 1993). In addition, deletions Since nuclear pathology has also been suggested to
of ApoER2 give rise to a number of phenotypes, includ- be an important player in polyglutamine disesases (re-
ing hyperphosphorylation of tau, as does deletion of viewed in Freiman and Tjian, 2002), an interesting possi-
disabled, a protein that binds to and may mediate signal- bility is that the context in which aggregating domains
ing from ApoER2 and VLDLR (Brich et al., 2003; Hies- are found might cause disease through multiple mecha-
berger et al., 1999). A recent QTL analysis reported that nisms by targeting toxic species to different cellular
changes in tau phosphorylation caused by disabled de- domains. Aggregating regions in nuclear targeted pro-
letions were strongly influenced by genetic variation in teins may lead to nuclear dysfunction, perhaps via tran-
regions that include the APP and presenilin genes (Brich scription factor titration (reviewed in Freiman and Tjian,
et al., 2003). Thus, although circumstantial, these obser- 2002), while targeting to axons, e.g., in the vesicle-asso-
vations again potentially point in the direction of kinesin- ciated protein huntingtin, may lead to axonal blockages.
mediated vesicular transport, pathological tau phosphory- Recent evidence supports this idea. A polyglutamine
lation, and neuronal dysfunction being tied together. In protein targeted to the nucleus caused neuronal apopto-
fact, a virtue of this view is that it provides a potential sis but not axonal blockage, while a polyglutamine pro-
mechanistic link between the major pathological fea- tein targeted to the cytoplasm caused axonal blockages
tures that characterize AD, namely the tau protein found and organismal death but not neuronal apoptosis (Gu-
in neurofibrillary tangles and APP, whose fragments lead nawardena et al., 2003). In this regard, axonal patholo-
to the formation of amyloid plaques. gies were also reported for prion diseases such as CJD
For Huntington’s disease (HD), a number of observa- that are also characterized by protein aggregation (Esiri
tions also point to linkage to the transport machinery. et al., 2000; Jeffrey et al., 1992, 1997; Liberski, 1996;
For example, a huntingtin binding protein called HAP1 Liberski et al., 1991, 1993, 2002a, 2002b). Finally, trans-
has been reported to interact with a major protein sub- genic mice expressing disease-related proteins in-
unit of the dynactin complex, which is important for cluding tau and Apo-E exhibit axonal transport deficits
dynein-based, and possibly kinesin-based, transport and prominent axonal swellings (Spittaels et al., 1999;
(Engelender et al., 1997; Li et al., 1998). In addition, Tesseur et al., 2000), reminiscent of axonal transport
huntingtin is a vesicular protein transported in both an- blockages in Drosophila models.
terograde and retrograde fast transport pathways While transport failure cannot yet account for all as-
(Block-Galarza et al., 1997). Of interest to HD is the pects of these neurodegenerative diseases, it does ac-
finding from several groups that dystrophic neurites in count for a few puzzling properties of these diseases.
HD exhibit characteristics of blocked axons, i.e., accu- For example, many disease-causing proteins are broadly
mulations of vesicles and organelles in swollen axonal expressed, but only cause neuronal dysfunction when
projections and termini (DiFiglia et al., 1997; Sapp et mutant. This cell-type specificity may reflect the obvious
al., 1999). In particular, analysis of a huntingintin 150Q fact that neurons have long narrow axonal and dendritic
knockin mouse mutant revealed clear axonal pathology processes while epithelial and most other cells do not.
in striatal axons (Li et al., 2001) characteristic of trans-
Whether this view can account for cell-type specificity
port failures and virtually identical to the phenotype of
in the nervous system remains to be seen, but certainly
motor protein mutants in Drosophila (Hurd and Saxton,
axonal diameter, flux of different transport pathways,1996) (compare Figure 4 of Li et al., 2001 to Figure 2 of
and other factors may account for how failures of theHurd and Saxton, 1996) and of polyglutamine-induced
generic process of transport in neurons could causeaxonal blockages recently found in Drosophila models
preferential neuronal loss (Figure 3).of polyglutamine disease (Gunawardena et al., 2003).
How these phenotypes arise and whether these axonal
Directions for the Future-Neededphenotypes are early causes of neurodegeneration or
New Technologiesmerely steps on the pathway of degeneration remains
There is considerable circumstantial evidence from workunknown and needs to be tested rigorously.
in model organisms that proteins linked to neurodegen-A second pathological mechanism may be caused by
erative disease in humans may also play roles in theexpression of aggregating proteins in narrow axonal or
transport machinery, and that these functions may godendritic processes. Perhaps aggregates of any type of
awry in disease. How can this work be extended toprotein, if they become large enough, can physically
humans? Several avenues of approach seem likely toblock or impair transport in narrow axons or dendrites
be most productive in the future. First and most obvious(Figure 3). Examples of this phenomenon may be pro-
is that genetic work on hereditary forms of disease andvided by polyglutamine diseases such as SCA6 where
predisposing genetic factors may directly implicateaxonal “torpedoes,” which appear to be composed of
some motor proteins. But, what of sporadic disease oraccumulated neurofilaments and other materials that
fail to be transported, are prominent features of the disease where nonspecific insult to the transport ma-
Neuron
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Figure 3. Diagram of Some Possible Mecha-
nisms and Predisposing Features that Might
Lead to Axonal Blockage and Transport
Failures
Normal transport is characterized by move-
ment of vesicles and organelles along micro-
tubules in axons and dendrites. Mutations in
genes encoding motor proteins or their adap-
tor proteins or mutations in genes causing
some neurodegenerative diseases might
block transport by directly causing vesicle
and organelle stalling or by the generation
of cytosolic or intravesicular aggregates in
axons or dendrites. Cellular features that
might predispose different populations of
neurons to transport failures might include
total or specific flux, axonal length, axonal
diameter, motor dosage, and different muta-
tions.
in the axon and nonuniformity in the dendrite. Proc. Natl. Acad. Sci.chinery may be the causative element? One possibility
USA 85, 8335–8339.is the development of axonal transport assays in living
Berg, J.S., Powell, B.C., and Cheney, R.E. (2001). A millennial myosinpatients by vital imaging methods. Another possibility
census. Mol. Biol. Cell 12, 780–794.is that modeling some of these diseases in neurons in
Block-Galarza, J., Chase, K.O., Sapp, E., Vaughn, K.T., Vallee, R.B.,culture may be critical. For example, perhaps human
DiFiglia, M., and Aronin, N. (1997). Fast transport and retrograde
embryonic stem cell technology can be used to make movement of huntingtin and HAP 1 in axons. Neuroreport 8, 2247–
human neurons in culture that express mutant hunting- 2251.
tin, APP, presenilin, etc. Such cells can then be used to Bowen, D.M., Benton, J.S., Spillane, J.A., Smith, C.C., and Allen,
test hypotheses developed in animal models in human S.J. (1982). Choline acetyltransferase activity and histopathology of
frontal neocortex from biopsies of demented patients. J. Neurol.neurons directly, eliminating at least one major variable
Sci. 57, 191–202.in understanding disease, namely the potential differ-
Bowman, A.B., Kamal, A., Ritchings, B.W., Philp, A.V., McGrail, M.,ences between mice and humans. Such cells may also
Gindhart, J.G., and Goldstein, L.S. (2000). Kinesin-dependent axonalprove to be critical in the development of new therapeu-
transport is mediated by the sunday driver (SYD) protein. Celltic reagents, i.e., drugs. Finally, the transport hypothesis
103, 583–594.
of neuronal disease makes some key predictions,
Brich, J., Shie, F.S., Howell, B.W., Li, R., Tus, K., Wakeland, E.K.,
namely that pathologies characteristic of transport fail- Jin, L.W., Mumby, M., Churchill, G., Herz, J., and Cooper, J.A. (2003).
ures should occur early in the course of disease, prior Genetic modulation of tau phosphorylation in the mouse. J. Neu-
to the onset of behavioral or other symptoms and prior rosci. 23, 187–192.
to other pathologies. Burack, M.A., Silverman, M.A., and Banker, G. (2000). The role of
selective transport in neuronal protein sorting. Neuron 26, 465–472.While it is still early in our developing understanding
of these relationships, I am optimistic about the poten- Ching, G.Y., Chien, C.L., Flores, R., and Liem, R.K. (1999). Overex-
pression of alpha-internexin causes abnormal neurofilamentous ac-tial of understanding devastating neuronal diseases by
cumulations and motor coordination deficits in transgenic mice. J.use of this paradigm. Key to our understanding will be
Neurosci. 19, 2974–2986.to distinguish diseases where transport failure is an early
Cooper, J.D., Salehi, A., Delcroix, J.D., Howe, C.L., Belichenko, P.V.,pathological consequence of a different early lesion, as
Chua-Couzens, J., Kilbridge, J.F., Carlson, E.J., Epstein, C.J., and
opposed to those in which transport failure is a true Mobley, W.C. (2001). Failed retrograde transport of NGF in a mouse
initiating cause. In either case, pharmacological inter- model of Down’s syndrome: reversal of cholinergic neurodegenera-
vention in the transport process may be a valuable ave- tive phenotypes following NGF infusion. Proc. Natl. Acad. Sci. USA
98, 10439–10444.nue for the development of therapies for diseases where
we currently have no therapeutic methods. Coy, D.L., Hancock, W.O., Wagenbach, M., and Howard, J. (1999).
Kinesin’s tail domain is an inhibitory regulator of the motor domain.
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